The 3rd “China Quality Awards” ceremony was held in Beijing on November 2, 2018. ASK Pharm was awarded a “China Quality Award (Nomination Award)” by the State Administration for Market Regulation (SAMR), for its “comprehensive and innovative corporate management emphasizing on health”. The recognition of a “China Quality Award” at the national stage is another significant milestone and outstanding accomplishment for ASK Pharm, which has consecutively secured various high-impact awards including “Nanjing Mayor Quality Award”, “Jiangsu Provincial Quality Award”, and “Global Performance Excellence Award” in recent years. “China Quality Awards” is the highest award issued by the Chinese Government, which recognize the outstanding performance, quality innovation and management executed by manufacturing industry, service sectors, hospitals, education organizations and individuals at the national level. This year, the selection of “China Quality Award (Nomination Award)” has been highly competitive among more than 300 manufacturing companies from a wide variety of disciplines. The final “China Quality Awards (Nomination Award)” were given to 31 organizations under the manufacturing industry category, among which there were 4 finalists from the pharmaceutical industry. ASK Pharm is the only awardee from the City of Nanjing.
ASK Pharm was founded by Dr. Qingcai Chen, President and CEO, and is a research-based pharmaceutical enterprise specializing in proton pump inhibitor (PPI) injection products and other proprietary oncology medicines. With Corporate Vision of “Driven for Health, Growth on Health”, ASK Pharm has become a leading pharmaceutical manufacturer in China, making significant contributions to innovative research and development in quality pharmaceutical products and improvement of general public health and quality of life. ASK Pharm has consistently adhered to Corporate Mission of “Based on Research, Oriented for Health”, by optimizing management, operating, quality monitoring and surveillance. This “comprehensive and innovative management model emphasizing on the health of both ASK Brand and ASK products” is not only the foundation of ASK’s successes at the national level, but will also assure the continued successes of ASK Pharm in years to come.
The Chinese government of all levels have always stressed the importance of quality and effective pharmaceuticals, and prioritized management reform and product innovation to assure public health and well-being. The government’s new strategy of “Quality First, Strong Country” will inspire ASK Pharm to perfect its innovative management and operation system to keep abreast of current national regulatory standards and requirements. The achievement of a “China Quality Award (Nomination Award)” by ASK Pharm is merely a new start-point for us, ASK will make continued and persistent efforts in maintaining ASK Brand reputation, developing more propriety ASK innovations, and producing more specialized ASK products. Ultimately, ASK Pharm endeavors to make significant contributions to improving competitiveness of Chinese pharmaceutical industry and ensuring the qualities and strengths of Chinese pharmaceuticals both nationally and internationally.
